http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8753675-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92a8a8e8163cd039600087bc43113c38 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2000-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48b27c9e73e080e9370fd34cd3536cd1 |
| publicationDate | 2014-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8753675-B1 |
| titleOfInvention | Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications |
| abstract | The present invention relates to a reduced form of Coenzyme Q also known as ubiquinol in oral dosage form such as a gelatin capsule, preferably a soft gelatin capsule. Compositions according to the present invention include storage stable compositions comprising effective amounts of ubiquinol in combination with an amount of a reducing agent effective to maintain ubiquinol in its reduced state when formulated in capsules, tablets and other orally administrable form. Methods of using these compositions in the treatment of a number of disease states or conditions are also disclosed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400058-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973763-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471426-B2 |
| priorityDate | 2000-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 544.